mGluR4-NPDC1 complex mediates α-synuclein fibril-induced neurodegeneration

Area of Science:

• Neuroscience
• Molecular Biology
• Cell Biology

Background:

• Alpha-synuclein (α-syn) fibrils are central to Parkinson's disease (PD) pathogenesis.
• Cell-to-cell transmission of α-syn fibrils contributes to neurodegeneration in PD.
• Understanding α-syn fibril entry into neurons is crucial for developing PD therapies.

Purpose of the Study:

• To identify neuronal surface proteins involved in α-syn fibril binding and internalization.
• To investigate the role of identified proteins in α-syn-mediated neurodegeneration.
• To explore the therapeutic potential of targeting these proteins in PD models.

Main Methods:

• Comprehensive membrane proteome analysis to identify α-syn fibril binding partners.
• Genetic manipulation (gene deletion and heterozygosity) in mouse models of PD.
• In vitro studies using cultured neurons to assess α-syn fibril uptake and synaptic integrity.

Main Results:

• Metabotropic glutamate receptor 4 (mGluR4) and Nuclear protein domain containing 1 (NPDC1) were identified as key nigral surface proteins that bind and internalize α-syn fibrils.
• Deletion of Grm4 or Npdc1 in mice conferred protection against α-syn fibril-induced dopamine neuron loss.
• mGluR4 and NPDC1 form a complex that regulates mGluR4 function and mediates α-syn fibril uptake, leading to neurodegeneration.

Conclusions:

• A cell surface mGluR4-NPDC1 complex is critically involved in the neurodegenerative process of Parkinson's disease by mediating α-syn fibril entry into neurons.
• Targeting the mGluR4-NPDC1 complex presents a potential therapeutic strategy for Parkinson's disease.
• Genetic interaction between Grm4 and Npdc1 highlights their collaborative role in α-syn pathogenesis.